Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 7-14 , January 2010

Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection

  • M. Franciosi

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • A. Maione

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • B. Pomili

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • R. Amoretti

      Affiliations

    • Diabetes Unit, Azienda Ospedaliera S. Giovanni Addolorata, Roma, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • E. Busetto

      Affiliations

    • Fondazione Medtronic Italia, Sesto San Giovanni (MI), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • F. Capani

      Affiliations

    • Department of Medicine and Ageing, University “G. D'Annunzio”, Chieti, Italy
    • OnLine University “Leonardo da Vinci” – Torrevecchia Teatina (CH), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • D. Bruttomesso

      Affiliations

    • Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • P. Di Bartolo

      Affiliations

    • Diabetes Unit, AUSL Provincia di Ravenna, Ravenna, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • A. Girelli

      Affiliations

    • Diabetes Unit, Spedali Civili di Brescia, Brescia, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • F. Leonetti

      Affiliations

    • Department of Clinical Sciences, La Sapienza University, Roma, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • L. Morviducci

      Affiliations

    • Diabetes Unit, San Camillo Hospital, Roma, Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • P. Ponzi

      Affiliations

    • Fondazione Medtronic Italia, Sesto San Giovanni (MI), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • E. Vitacolonna

      Affiliations

    • Department of Medicine and Ageing, University “G. D'Annunzio”, Chieti, Italy
    • OnLine University “Leonardo da Vinci” – Torrevecchia Teatina (CH), Italy
    • On behalf of the EQuality1 Study Group.
    • ,
  • A. Nicolucci

      Affiliations

    • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
    • Corresponding Author InformationCorresponding author. Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 8/A - 66030 Santa Maria Imbaro (Chieti), Italy. Tel.: +39 0872570260; fax: +39 0872570263.
    • On behalf of the EQuality1 Study Group.

Received 18 November 2008 ,Revised 20 February 2009 ,Accepted 20 February 2009.

References 

  1. The Diabetes Control and Complications Trial (DCCT) Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  2. Mecklenburg RS, Benson EA, Benson JW, Blumenstein BA, Fredlund PN, Guinn TS, et al. Long-term metabolic control with insulin pump therapy. Report of experience with 127 patients. N Engl J Med. 1985;313:465–468
  3. Santiago JV. Clinical review 38: intensive management of insulin dependent diabetes: risks, benefits, and unanswered questions. J Clin Endocrinol Metab. 1992;75:977–982
  4. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care. 1996;19:324–327
  5. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J. 1986;293:1195–1199
  6. Rodrigues IAS, Reid HA, Ismail K, Amiel SA. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med. 2005;22:842–849
  7. Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabet Med. 2007;24:607–617
  8. EQuality1 Study Group – Evaluation of QUALITY of Life and Costs in Diabetes Type 1 , Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, et al Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med. 2008;25:213–220
  9. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006;23:141–147
  10. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care. 2001;24:1870–1877
  11. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with Type 1 diabetes. Diabetes Care. 1998;21:757–769
  12. Bott U, Ebrahim S. Further development of a quality-of-life measure for IDDM patients (Abstract). Diabetologia. 1998;41:A74
  13. Ware JE, Gandek BL, Keller SD, the IQOLA Project Group . Evaluating instruments used cross-nationally: methods from the IQOLA project. In:  Spilker B editors. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.. Philadelphia: Lippincott-Raven Publishers; 1996;p. 681–692
  14. Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF, et al. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol. 2007;2:984–991
  15. Ciampi A. Constructing prediction trees from data: the RECPAM approach. In: Proceedings from the Prague 1991 summer school on computational aspects of model choice. Heidelberg: Physica-Verlag; 1992;p. 165–178
  16. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141–155
  17. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20:562–567
  18. Huang GH, Palta M, Allen C, LeCaire T, D'Alessio D. Wisconsin Diabetes Registry. Self-rated health among young people with Type 1 diabetes in relation to risk factors in a longitudinal study. Am J Epidemiol. 2004;159:364–372
  19. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, et al. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009;19:45–53

☆ Parts of this study have been presented at the 44th EASD Annual Meeting Roma, Italy – September 7–11 2008.

PII: S0939-4753(09)00043-X

doi: 10.1016/j.numecd.2009.02.012

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 7-14 , January 2010

Article Tools

* Image Usage & Resolution